Lilly receives UK marketing authorisation for tirzepatide (Mounjaro) in alternative Kwikpen presentation for two indications
top of page
Browse by category
Search
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Eli Lilly’s tirzepatide...
Journal Watch 24/1/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Banded sleeve gastrectomy outperforms standard LSG but has higher incidence of post-op regurgitation symptoms
Laparoscopic banded sleeve gastrectomy (LBSG) showed a substantial decrease in BMI at three-year follow-up and higher %EWL at one, two...
First NHS patients treated with Allurion Balloon for weight loss
Allurion Technologies has announced that the Somerset NHS Foundation Trust is the first NHS trust in the UK - and the first non-private...
Sciwind’s ecnoglutide oral GLP-1 analogue reveal positive results
Sciwind Biosciences has announced positive interim results from the first four cohorts of a Phase 1 clinical trial of oral ecnoglutide...
GLP1 agonists associated with a reduced risk of developing cirrhosis and liver cancer in people with T2DM and chronic liver disease
Glucagon-like peptide-1 receptor (GLP1) agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people...
Highlights from the 7th Gulf Obesity Surgery Society Conference, Ground breaking session for medical students
The 7th Gulf Obesity Surgery Society Conference unfolded its curtains in the vibrant city of Dubai, UAE, from December 15th to 16th,...
England experiences fastest growth in childhood overweight/obesity
England experienced the fastest and highest growth in the prevalence of childhood obesity among 11–15-year-olds, rising from 30% in 1995...
Bariatric surgery improves lung function in patients with obesity and asthma
Bariatric surgery, initiates "substantial weight loss and improves lung function, according to researchers from the University of...
ForePass endoscopic device results in 79% reduction in weight gain compared to the control group
The ForePass endoscopic device (Keyron Ltd.) results in a 79% reduction in weight gain compared to the control group in a swine model,...
Browse by tag
bottom of page